Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, ...

Experts say the approach could also save millions of pounds by cutting projects or clinical trials that would otherwise fail.

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugsRamat Gan, Israel, March 24, 2025 (GLOBE ...

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

Effective drug discovery and development hinge on high-quality data. Implementing FAIR principles enhances data usability and ...

Pheiron and Ribo are excited to announce that the first two strategic collaboration milestones have been successfully ...

The Microbiome Disease Pipeline Report 2025 reveals 180+ drugs under development across 140+ companies, covering late-stage, mid-stage, and early-stage therapies. Major players such as MaaT Pharma, ...

The ongoing conflicts between Ukraine and Russia, as well as Israel and Palestine, have sent ripples across various ...

Novo will license UTB251, a triple hormone receptor agonist that in mid-2023 achieved promising weight reduction in a ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

An experimental drug has shown promise in preventing Alzheimer’s for people at higher risk of developing the disease.

Amid Trump’s dismantling of DEI, Roche wiped diversity targets from the website of its US subsidiary, Genentech, in mid-February. Basel-based competitor Novartis also said this week it was getting rid ...